Shayna Sarosiek, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia (NCT06986174) | Shayna Sarosiek, MD | 2025-11-21 |
| Loncastuximab Tesirine in WM (NCT05190705) | Shayna Sarosiek, MD | 2022-02-17 |
| ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy (NCT05065554) | Shayna Sarosiek, MD | 2021-11-16 |
Track Shayna Sarosiek, MD automatically
Every clearance here is in the API, with alerts when new ones post.